Form 8-K - Current report:
SEC Accession No. 0001437749-25-036076
Filing Date
2025-11-24
Accepted
2025-11-24 08:00:43
Documents
14
Period of Report
2025-11-24
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K bcda20251121_8k.htm   iXBRL 8-K 27619
2 EXHIBIT 99.1 ex_892143.htm EX-99.1 8654
  Complete submission text file 0001437749-25-036076.txt   169749

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bcda-20251124.xsd EX-101.SCH 3581
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bcda-20251124_def.xml EX-101.DEF 11426
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcda-20251124_lab.xml EX-101.LAB 15312
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcda-20251124_pre.xml EX-101.PRE 11586
16 EXTRACTED XBRL INSTANCE DOCUMENT bcda20251121_8k_htm.xml XML 2824
Mailing Address 320 SOQUEL WAY SUNNYVALE CA 94085
Business Address 320 SOQUEL WAY SUNNYVALE CA 94085 650-226-0123
BioCardia, Inc. (Filer) CIK: 0000925741 (see all company filings)

EIN.: 232753988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38999 | Film No.: 251509622
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)